SAB Biotherapeutics, Inc. (SABS): 8-K filed Oct 13, 2026

Form type

8-K

Filing date

Oct 13, 2026

Accession number

0001193125-26-419769

Filer

SAB Biotherapeutics, Inc. (CIK 1833214)